Structure

InChI Key OMFNSKIUKYOYRG-MOSHPQCFSA-N
Smiles CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
InChI
InChI=1S/C24H31NO4/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20/h9-10,13-16,25H,5-8,11-12H2,1-4H3/b20-13-

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H31NO4
Molecular Weight 397.52
AlogP 4.93
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 9.0
Polar Surface Area 48.95
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 29.0

Pharmacology

Mechanism of Action Action Reference
Phosphodiesterase 4 inhibitor INHIBITOR Other Patent Patent
Protein: Phosphodiesterase 4

Description: cAMP-specific 3',5'-cyclic phosphodiesterase 4A

Organism : Homo sapiens

P27815 ENSG00000065989
Protein: Phosphodiesterase 4

Description: cAMP-specific 3',5'-cyclic phosphodiesterase 4B

Organism : Homo sapiens

Q07343 ENSG00000184588
Protein: Phosphodiesterase 4

Description: cAMP-specific 3',5'-cyclic phosphodiesterase 4C

Organism : Homo sapiens

Q08493 ENSG00000105650
Protein: Phosphodiesterase 4

Description: cAMP-specific 3',5'-cyclic phosphodiesterase 4D

Organism : Homo sapiens

Q08499 ENSG00000113448
Assay Description Organism Bioactivity Reference
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 87.86 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 9.312 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.05 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.05 %

Cross References

Resources Reference
ChEBI 135630
ChEMBL CHEMBL551978
DrugBank DB06751
DrugCentral 969
FDA SRS 98QS4N58TW
Human Metabolome Database HMDB0015669
PharmGKB PA165958398
PubChem 1712095
SureChEMBL SCHEMBL196438
ZINC ZINC000100011979